Postgraduate Medicine

• 

  Publication Venue For

  • Implications of differing attitudes and experiences between providers and persons with obesity: results of the national ACTION study..  131:357-365. 2019
  • Response to: 'Pharmacokinetic/pharmacodynamic properties and efficacy/safety of U-500R from randomized clinical studies'..  128:686. 2016
  • A primer on concentrated insulins: what an internist should know..  128:381-390. 2016
  • Understanding the type 2 diabetes mellitus and cardiovascular disease risk paradox..  126:190-204. 2014
  • Alternatives to warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a look back at the state of the field in 2012..  125:146-157. 2013
  • The dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus: cardiovascular safety..  124:54-61. 2012
  • PDI-4A: an augmented provisional screening instrument assessing 5 additional common anxiety-related diagnoses in adult primary care patients..  123:89-95. 2011
  • A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes..  122:16-27. 2010
  • Strategies for implementing and sustaining therapeutic lifestyle changes as part of hypertension management in African Americans..  121:147-159. 2009
  • Continuum of care in the treatment of ST-segment elevation myocardial infarction (STEMI): importance of platelet and coagulation inhibition..  120:67-78. 2008
  • Pathophysiologic mechanisms of anemia of chronic disease..  116:17-22. 2004
  • Drug-induced meningitis..  96:117-124. 1994
  • Benign prostatic hyperplasia..  94:141-152. 1993
  • Prostatitis..  94:191-194. 1993